tiprankstipranks
Advertisement

EFAV - ETF AI Analysis

Compare

Top Page

EFAV

iShares MSCI EAFE Min Vol Factor ETF (EFAV)

Rating:61Neutral
Price Target:
EFAV’s rating suggests it is a solid, quality-focused ETF, helped by strong core holdings like Novartis, DBS Group, Zurich Insurance, and BOC Hong Kong, which all show robust financial performance, reasonable valuations, and generally positive earnings call sentiment. Some holdings, such as Takeda Pharmaceutical and OCBC, face issues like overvaluation, mixed earnings results, or weaker cash flow, which slightly weigh on the fund’s overall appeal. A key risk factor is the ETF’s reliance on a concentrated set of large international companies, meaning challenges in a few major holdings or regions could have an outsized impact on performance.
Positive Factors
Strong Year-To-Date Performance
The ETF has delivered strong gains so far this year, showing solid recent momentum for investors.
Resilient Top Holdings
Most of the largest positions, including major energy, financial, and healthcare companies, have shown strong or steady performance, helping support the fund’s returns.
Broad International Diversification
The fund spreads its investments across many countries outside the U.S., with meaningful exposure to Japan, the UK, Switzerland, and several other markets, which helps reduce reliance on any single economy.
Negative Factors
Heavy Japan Exposure
A large portion of the portfolio is invested in Japan, which means the fund’s results are strongly tied to how that single market performs.
Mixed Short-Term Performance
While the fund has done well year-to-date, its recent three-month performance has been weak, suggesting some loss of near-term momentum.
Moderate Fee Level
The expense ratio is not especially high but also not the lowest available, so costs still slightly reduce the returns investors keep.

EFAV vs. SPDR S&P 500 ETF (SPY)

EFAV Summary

EFAV is the iShares MSCI EAFE Min Vol Factor ETF, which follows the MSCI EAFE Minimum Volatility Index. It invests in stocks from developed countries outside North America, such as Japan, the UK, and Europe, and aims to smooth out big market swings by focusing on companies with more stable share prices. Well-known holdings include Shell and Novartis. An investor might choose EFAV to add international diversification with a tilt toward lower-volatility stocks, seeking steadier long-term growth. A key risk is that it can still lose value and will rise and fall with global stock markets.
How much will it cost me?The iShares MSCI EAFE Min Vol Factor ETF (EFAV) has an expense ratio of 0.20%, which means you’ll pay $2 per year for every $1,000 invested. This is lower than the average for actively managed funds because EFAV is passively managed, tracking an index that focuses on minimizing volatility in developed markets outside North America.
What would affect this ETF?The EFAV ETF could benefit from stable economic growth in developed markets outside North America, particularly in sectors like financials, consumer defensive, and healthcare, which are well-represented in its portfolio. However, it may face challenges from rising interest rates, which could impact financial stocks, or geopolitical tensions in Europe and Asia that might affect market stability. Regulatory changes in these regions or shifts in global trade policies could also influence the ETF's performance.

EFAV Top 10 Holdings

EFAV leans on a mix of steady global blue chips, with energy and financial names doing much of the heavy lifting. DBS Group is a key engine, rising on strong profitability and rate tailwinds, while Shell, ENI, and TotalEnergies give the fund extra fuel as energy stocks climb. On the defensive side, Novartis and Zurich Insurance add stability, though Zurich’s momentum has been more mixed. Takeda is losing steam a bit, modestly lagging peers. Overall, the ETF is broadly diversified across developed markets outside North America, with no single stock dominating the story.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
Iberdrola1.52%$82.86M€136.51B31.71%
67
Neutral
DBS Group Holdings1.50%$81.71MS$216.90B58.94%
78
Outperform
Shell (UK)1.48%$80.40M£181.34B24.71%
73
Outperform
1.47%$80.08M
Takeda Pharmaceutical Co1.46%$79.27M¥8.84T21.73%
66
Neutral
ENI S.p.A.1.44%$78.29M€68.09B59.57%
63
Neutral
Secom Co1.43%$77.90M¥3.04T1.18%
73
Outperform
Novartis AG1.41%$76.91MCHF230.61B32.06%
80
Outperform
OCBC1.40%$75.97MS$136.17B70.40%
71
Outperform
TotalEnergies SE1.38%$74.99M€165.38B44.08%
78
Outperform

EFAV Technical Analysis

Technical Analysis Sentiment
Positive
Last Price
Price Trends
50DMA
90.02
Positive
100DMA
89.87
Positive
200DMA
88.04
Positive
Market Momentum
MACD
1.02
Positive
RSI
62.46
Neutral
STOCH
56.23
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For EFAV, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 92.37, equal to the 50-day MA of 90.02, and equal to the 200-day MA of 88.04, indicating a bullish trend. The MACD of 1.02 indicates Positive momentum. The RSI at 62.46 is Neutral, neither overbought nor oversold. The STOCH value of 56.23 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for EFAV.

EFAV Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$5.45B0.20%
61
Neutral
$9.36B0.35%
65
Neutral
$6.59B0.07%
66
Neutral
$2.24B0.58%
66
Neutral
$2.08B0.20%
59
Neutral
$1.50B0.40%
65
Neutral
Performance Comparison
Ticker
Company Name
Price
Change
% Change
EFAV
iShares MSCI EAFE Min Vol Factor ETF
93.37
11.15
13.56%
DBEF
Xtrackers MSCI EAFE Hedged Equity ETF
BBIN
JPMorgan BetaBuilders International Equity ETF
IHDG
WisdomTree International Hedged Quality Dividend Growth Fund
HFXI
IQ 50 Percent Hedged FTSE International ETF
DDWM
WisdomTree Dynamic Currency Hedged International Equity Fund
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement